Natco Pharma - Board Meeting Intimation for Approval Of Audited Results, Considering 3Rd Interim Dividend And Convening 36Th
18/05/2019 11:11
NATCO PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2019 ,inter alia, to consider and approve 1. Approval of Audited Financial Results for the quarter and
year ended March 31, 2019
2. Considering 3rd Interim Dividend for the financial year
2018-2019
3. Convening of the 36th AGM and related matters